Submission for OMB Review; 30-Day Comment Request; The Study of the Center for Global Health's (CGH) Workshops (NCI), 25704-25706 [2015-10394]
Download as PDF
<![CDATA[
25704
Federal Register / Vol. 80, No. 86 / Tuesday, May 5, 2015 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos.93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Meeting
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NICHD.
The meeting will be open to the
public as indicated below, with the
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
EUNICE KENNEDY SHRIVER
NATIONAL INSTITUTE OF CHILD
HEALTH AND HUMAN
DEVELOPMENT, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NICHD.
Date: June 5, 2015.
Open: 8:00 a.m. to 11:45 a.m.
Agenda: A report by the Scientific Director,
NICHD, on the status of the NICHD Division
of Intramural Research, talks by various
intramural scientists, and proposed
organizational change.
Place: National Institutes of Health,
Building 31A, Conference Room 2A48, 31
Center Drive, Bethesda, MD 20892.
Closed: 11:45 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31A, Conference Room 2A48, 31
Center Drive, Bethesda, MD 20892.
Contact Person: Constantine A. Stratakis,
MD, D(med) Sci, Scientific Director, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, NIH,
Building 31A, Room 2A46, 31 Center Drive,
Bethesda, MD 20892, 301–594–5984,
stratakc@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
dir.nichd.nih.gov/dirweb/home.html, where
an agenda and any additional information for
the meeting will be posted when available.
VerDate Sep<11>2014
17:18 May 04, 2015
Jkt 235001
Dated: April 29, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–10388 Filed 5–4–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Arthritis and Musculoskeletal
and Skin Diseases Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: June 16, 2015.
Open: 8:30 a.m. to 12:30 p.m.
Agenda: Discussion of Program Policies.
Place: National Institutes of Health,
Building 31, 6th Floor, C Wing, Conference
Room #6, 31 Center Drive, Bethesda, MD
20892.
Closed: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 6th Floor, C Wing, Conference
Room #6, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Laura K. Moen, Ph.D.
Director, Division of Extramural Research
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Activities, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6700 Democracy
Boulevard, Suite 800, Bethesda, MD 20892,
301–451–6515, moenl@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: April 29, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–10407 Filed 5–4–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; The Study of the
Center for Global Health’s (CGH)
Workshops (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on May 8, 2014,
Vol. 79, page 26437 and allowed 60days for public comment. One public
comment was received on May 12, 2014.
The purpose of this notice is to allow an
additional 30 days for public comment.
The National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
SUMMARY:
E:\FR\FM\05MYN1.SGM
05MYN1
25705
Federal Register / Vol. 80, No. 86 / Tuesday, May 5, 2015 / Notices
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: NIH
Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Sudha Sivaram, Program
Director, Center for Global Health,
National Cancer Institute, 9609 Medical
Center Dr., RM 3W528, Rockville MD,
20850 or call non-toll-free number 240–
276–5804 or Email your request,
including your address to:
sudha.sivaram@nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: The Study of the
Center for Global Health’s (CGH)
Workshops (NCI), 0925—NEW, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: This submission is a request
for OMB to approve The Study of the
Center for Global Health’s (CGH)
Workshops for three years. This
information collection is to collect
stakeholder feedback from past
workshops and future workshops, to
assess the effectiveness of CGH
workshops, which seek to assess the
abilities of other countries to implement
national cancer control programs,
inform content and improve delivery of
future workshops, and to systematically
assess CGH’s contribution. The
workshops to be studied are the
Symposiums on Global Cancer
Research, Workshops in Cancer Control
Planning and Implementation, the
Summer Curriculum in Cancer
Prevention, Women’s Cancer Program
Summit, and Regional Grant Writing
and Peer Review Workshops. While
these workshops differ in content and
delivery style, their underlying goals are
the same; they intend to initiate and
enhance cancer control efforts, increase
capacity for cancer research, foster new
partnerships, and create research and
cancer control networks. The proposed
study requests information about the
outcomes of each of these workshops
including (1) new cancer research
partnerships and networks (2) cancer
control partnerships and networks, (3)
effects on cancer research, and (4) effect
on cancer control planning and
implementation efforts. Information will
be collected in two phases where Phase
1 will collect information from
attendees of past workshops (1998–
2015) and phase two will collect
information from attendees of future
workshops over the next three years.
This information will allow CGH to
assess the effectiveness of its workshops
in order to inform future programming
and funding decisions. The surveys will
enable CGH to better understand the
impact the workshops have had on their
partnerships and networks, research,
and cancer control planning and
implementation efforts.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
805.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
per year
Form name
Chief Executives, Medical Scientists, Health Educators,
Family/General Practitioners, Registered Nurses, Medical and Health Services Managers.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Type of respondents
Phase 1: Symposium on
Global Cancer Research.
Phase 2: Symposium on
Global Cancer Research.
Phase 1: Workshop in
Cancer Control Planning and Implementation for non-Ministry of
Health participants.
Phase 2: Workshop in
Cancer Control Planning and Implementation for non-Ministry of
Health participants.
Phase 1: Workshop in
Cancer Control Planning and Implementation for Ministry of
Health.
Phase 2: Workshop in
Cancer Control Planning and Implementation for Ministry of
Health.
Phase 1: Summer Curriculum in Cancer
Prevention.
Phase 2: Summer Curriculum in Cancer
Prevention.
Phase 1: Women’s Cancer Program Summit.
VerDate Sep<11>2014
17:18 May 04, 2015
Jkt 235001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total annual
burden
hours
500
1
20/60
167
250
1
20/60
83
70
1
20/60
23
70
1
20/60
23
70
1
20/60
23
70
1
20/60
23
500
1
30/60
250
27
1
30/60
14
140
1
20/60
47
E:\FR\FM\05MYN1.SGM
05MYN1
25706
Federal Register / Vol. 80, No. 86 / Tuesday, May 5, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
respondents
per year
Form name
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total annual
burden
hours
140
1
20/60
47
150
1
30/60
75
60
1
30/60
30
Phase 2: Women’s Cancer Program Summit.
Phase 1: Regional
Grant Writing and
Peer Review Workshop.
Phase 2: Regional
Grant Writing and
Peer Review Workshop.
Dated: April 27, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2015–10394 Filed 5–4–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
(CSAP) Drug Testing Advisory Board
(DTAB) will meet via web conference on
June 11–12, 2015, from 10:00 a.m. to
3:30 p.m. E.D.T. The DTAB will
convene in both open and closed
sessions on these two days.
The Board will meet in closed session
on June 11, 2015, from 10:00 a.m. to
3:30 p.m., to discuss the proposed
revisions to the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs. Therefore, this meeting is
closed to the public as determined by
the Administrator, SAMHSA, in
accordance with 5 U.S.C. 552b(c)(9)(B)
and 5 U.S.C. App. 2, Section 10(d).
On June 12, 2015, from 10:00 a.m. to
3:30 p.m., the meeting will be open to
the public. The meeting will include
updates on the previously announced
DTAB recommendations, the public
comments to the request for information
on hair, DTAB’s process for evaluating
the scientific supportability of alternate
specimens for federal workplace drug
testing programs, HHS approval of
entities that certify medical review
officers, and the federal custody and
control form. The meeting also will
include drug testing updates from the
VerDate Sep<11>2014
17:18 May 04, 2015
Jkt 235001
Department of Transportation, the
Nuclear Regulatory Commission, the
Department of Defense, and the Federal
Drug-Free Workplace Programs.
The public is invited to attend via
web conference. Due to the limited callin capacity, registration is requested.
Public comments are welcome. To
obtain the web conference call-in
numbers and access codes, submit
written or brief oral comments, or
request special accommodations for
persons with disabilities, please register
at the SAMHSA Advisory Committees
Web site at https://nac.samhsa.gov/
Registration/meetingsRegistration.aspx
or contact the CSAP DTAB Designated
Federal Official, Dr. Janine Denis Cook
(see contact information below).
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committees Web site, https://
www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Dr. Cook.
Committee Name: Substance Abuse
and Mental Health Services
Administration’s Center for Substance
Abuse Prevention Drug Testing
Advisory Board.
Dates/Time/Type: June 11, 2015, from
10:00 a.m. to 3:30 p.m. E.D.T.: CLOSED,
June 12, 2015, from 10:00 a.m. to 3:30
p.m. E.D.T.: OPEN.
Place: SAMHSA Building, 1 Choke
Cherry Road, Rockville, Maryland
20850.
Contact: Janine Denis Cook, Ph.D.,
Designated Federal Official, CSAP Drug
Testing Advisory Board, 1 Choke Cherry
Road, Room 7–1043, Rockville,
Maryland 20857, Telephone: 240–276–
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
2600, Fax: 240–276–2610, Email:
janine.cook@samhsa.hhs.gov.
Janine Denis Cook,
Designated Federal Official, DTAB, Division
of Workplace Programs, Center for Substance
Abuse Prevention, Substance Abuse and
Mental Health Services Administration.
[FR Doc. 2015–10473 Filed 5–4–15; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2015–0013]
Meeting: Homeland Security Advisory
Council
The Office of
Intergovernmental Affairs, DHS.
ACTION: Notice of partially closed
Federal Advisory Committee meeting.
AGENCY:
The Homeland Security
Advisory Council (HSAC) will meet in
person on May 21, 2015. Members of the
public may participate in person. The
meeting will be partially closed to the
public.
DATES: The HSAC will meet Thursday,
May 21, 2015, from 11:00 a.m. to 5:15
p.m. EDT. The meeting will be open to
the public from 1:45 p.m. to 4:00 p.m.
EDT. Please note that the meeting may
close early if the Council has completed
its business. The portion from 11:00
a.m. to 1:30 p.m. EDT and 4:15 p.m. to
5:15 p.m. EDT will be closed to the
public.
SUMMARY:
The meeting will be held at
the Woodrow Wilson International
Center for Scholars (‘‘Wilson Center’’),
located at 1300 Pennsylvania Avenue
NW., Washington, DC 20004. All
visitors will be processed through the
lobby of the Wilson Center. Written
public comments prior to the meeting
must be received by 5:00 p.m. EDT on
May 15, 2015, and must be identified by
Docket No. DHS–2015–0013. Written
ADDRESSES:
E:\FR\FM\05MYN1.SGM
05MYN1
]]>Agencies
[Federal Register Volume 80, Number 86 (Tuesday, May 5, 2015)]
[Notices]
[Pages 25704-25706]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10394]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; The Study of
the Center for Global Health's (CGH) Workshops (NCI)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH), has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on May 8, 2014, Vol. 79, page 26437 and allowed 60-days for
public comment. One public comment was received on May 12, 2014. The
purpose of this notice is to allow an additional 30 days for public
comment. The National Cancer Institute (NCI), National Institutes of
Health, may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated
[[Page 25705]]
public burden and associated response time, should be directed to the:
Office of Management and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by fax to 202-395-6974, Attention: NIH
Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, or request more information on the
proposed project, contact: Sudha Sivaram, Program Director, Center for
Global Health, National Cancer Institute, 9609 Medical Center Dr., RM
3W528, Rockville MD, 20850 or call non-toll-free number 240-276-5804 or
Email your request, including your address to: sudha.sivaram@nih.gov.
Formal requests for additional plans and instruments must be requested
in writing.
Proposed Collection: The Study of the Center for Global Health's
(CGH) Workshops (NCI), 0925--NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information Collection: This submission is a
request for OMB to approve The Study of the Center for Global Health's
(CGH) Workshops for three years. This information collection is to
collect stakeholder feedback from past workshops and future workshops,
to assess the effectiveness of CGH workshops, which seek to assess the
abilities of other countries to implement national cancer control
programs, inform content and improve delivery of future workshops, and
to systematically assess CGH's contribution. The workshops to be
studied are the Symposiums on Global Cancer Research, Workshops in
Cancer Control Planning and Implementation, the Summer Curriculum in
Cancer Prevention, Women's Cancer Program Summit, and Regional Grant
Writing and Peer Review Workshops. While these workshops differ in
content and delivery style, their underlying goals are the same; they
intend to initiate and enhance cancer control efforts, increase
capacity for cancer research, foster new partnerships, and create
research and cancer control networks. The proposed study requests
information about the outcomes of each of these workshops including (1)
new cancer research partnerships and networks (2) cancer control
partnerships and networks, (3) effects on cancer research, and (4)
effect on cancer control planning and implementation efforts.
Information will be collected in two phases where Phase 1 will collect
information from attendees of past workshops (1998-2015) and phase two
will collect information from attendees of future workshops over the
next three years. This information will allow CGH to assess the
effectiveness of its workshops in order to inform future programming
and funding decisions. The surveys will enable CGH to better understand
the impact the workshops have had on their partnerships and networks,
research, and cancer control planning and implementation efforts.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 805.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average Total
Number of responses burden per annual
Type of respondents Form name respondents per response burden
per year respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Chief Executives, Medical Phase 1: Symposium on 500 1 20/60 167
Scientists, Health Educators, Global Cancer
Family/General Practitioners, Research.
Registered Nurses, Medical and
Health Services Managers.
Phase 2: Symposium on 250 1 20/60 83
Global Cancer
Research.
Phase 1: Workshop in 70 1 20/60 23
Cancer Control
Planning and
Implementation for
non-Ministry of
Health participants.
Phase 2: Workshop in 70 1 20/60 23
Cancer Control
Planning and
Implementation for
non-Ministry of
Health participants.
Phase 1: Workshop in 70 1 20/60 23
Cancer Control
Planning and
Implementation for
Ministry of Health.
Phase 2: Workshop in 70 1 20/60 23
Cancer Control
Planning and
Implementation for
Ministry of Health.
Phase 1: Summer 500 1 30/60 250
Curriculum in Cancer
Prevention.
Phase 2: Summer 27 1 30/60 14
Curriculum in Cancer
Prevention.
Phase 1: Women's 140 1 20/60 47
Cancer Program Summit.
[[Page 25706]]
Phase 2: Women's 140 1 20/60 47
Cancer Program Summit.
Phase 1: Regional 150 1 30/60 75
Grant Writing and
Peer Review Workshop.
Phase 2: Regional 60 1 30/60 30
Grant Writing and
Peer Review Workshop.
----------------------------------------------------------------------------------------------------------------
Dated: April 27, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2015-10394 Filed 5-4-15; 8:45 am]
BILLING CODE 4140-01-P
